Clinical trial reanalyses may alter who should get treated

Second scrutiny of published medical studies can conflict with first conclusion

Fresh looks at previously published clinical trial data can change recommendations about which patients to treat. In fact, in a new study, roughly one-third of reanalyses drew conclusions opposing the original ones.

Clinical trials, the gold standard of medical research, are rarely reanalyzed.